SINOVAC BIOTECH LTD SVA
SHS · Common Stock · CUSIP P8696W104
Chinese biopharm company
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersBeijing, People's Republic of China
- Founded1999
- Websitesinovac.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $21.49.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 32 |
| Q4 2022 | 10 |
| Q1 2023 | 5 |
| Q2 2023 | 31 |
| Q3 2023 | 31 |
| Q4 2023 | 8 |
| Q1 2024 | 27 |
| Q2 2024 | 27 |
| Q3 2024 | 9 |
| Q4 2024 | 4 |
| Q1 2025 | 3 |
| Q2 2025 | 29 |
| Q3 2025 | 27 |
| Q4 2025 | 28 |
| Q1 2026 | 28 |
| Q2 2026 | 29 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 1 | 18 |
| Q4 2024 | 0 | 5 |
| Q1 2025 | 0 | 1 |
| Q2 2025 | 26 | 0 |
| Q3 2025 | 7 | 3 |
| Q4 2025 | 4 | 3 |
| Q1 2026 | 7 | 5 |
| Q2 2026 | 6 | 7 |
Biggest buyers
| NAVELLIER & ASSOCIATES INC | New | +13.0k |
| Integrated Wealth Concepts LLC | New | +366 |
| UBS Group AG | Added | +250 |
| ASSETMARK, INC | Added | +37 |
| Buck Wealth Strategies, LLC | New | +7 |
| MORGAN STANLEY | Added | +2 |
Biggest sellers
| Skandinaviska Enskilda Banken AB (publ) | Reduced | -40.0k |
| OSAIC HOLDINGS, INC. | Reduced | -1.2k |
| WELLS FARGO & COMPANY/MN | Reduced | -231 |
| Horizon Investments, LLC | Reduced | -52 |
| Triumph Capital Management | Sold out | -14 |
| HARBOUR INVESTMENTS, INC. | Reduced | -5 |
| MAI Capital Management | Sold out | -3 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
1Globe Capital LLC
13D · may seek influence
no change · filed 2025-09-12
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On July 25, 2025, Vivo Capital Surplus Fund VIII, L.P. ("Vivo Fund VIII") filed an amended complaint (the "Amended Complaint") with the U.S. District Court for the Commonwealth of Massachusetts in the civil action initiated by Vivo Fund VIII on April 14, 2025 and previously disclosed in Amendment No. 6 to the Schedule 13D (the "Vivo Action"). In the Amended Complaint, Vivo Fund VIII alleges a disclosure violation claim under Section 13(d) of the Securities Exchange Act of 1934, repeating in a single count the allegations that appeared in its original complaint. Among other things, Vivo Fund VIII alleges that (1) Dr. Li has not filed a Schedule 13D and as a result investors do not know how many Sinovac shares he be… Full filing |
32.3% |
| SAIF Partners IV L.P. 13D · may seek influence no change · filed 2025-12-17 | 15.0% |
WEIDONG YIN
13D · may seek influence
no change · filed 2025-07-15
Stated purposeItem 4 is hereby amended and supplemented to add the following: The Issuer announced on July 10, 2025 a new board of directors of the Issuer (the "Board"), comprising Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y Yan (as Chairman of the Board) and the Reporting Person. The Reporting Person has accepted the appointment and plans to participate in the future governance of the Issuer as a member of the newly Board. Except as set forth in this Item 4, the Reporting Person has no present plan or intention that would resu lt in or relate to the listed transactions described in Item 4 of Schedule 13D. The Reporting Person has engaged and will continue to engage in discussions with other shareholders of… Full filing |
8.8% |
Advantech Capital L.P.
13D · may seek influence
no change · filed 2025-07-14
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On July 7, 2025, the High Court of Antigua and Barbuda granted an interim injunction prohibiting the Reporting Persons and certain other shareholders from voting their shares at the Special Meeting (the "Injunction Order"). On July 8, 2025, the Court of Appeal of the Eastern Caribbean Supreme Court issued an order staying the Injunction Order (the "Stay Order"). After the Court of Appeal issued the Stay Order, the Special Meeting of Shareholders of the Issuer requisitioned by SAIF Partners IV L.P. ("SAIF") (the "Special Meeting") was convened. Mr. Chiang Li delivered a short statement and then purported to adjourn the Special Meeting. The Reporting Persons understand that the shareholders attending the Special Meeting the… Full filing |
8.1% |
Vivo Capital VIII, LLC
13D · may seek influence
no change · filed 2025-07-11
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On May 19, 2025, the Issuer gave notice of a Special Meeting of Shareholders to be held on July 8, 2025 and announced an intention to exclude shares held by the Reporting Persons and another investor from the vote. On May 30, 2025, the Issuer filed an application for an injunction in the High Court of Antigua and Barbuda seeking an order prohibiting the Reporting Persons and the other investor from voting their shares at the Special Meeting. The Reporting Persons have opposed such an injunction in the High Court and the Court of Appeal of the Eastern Caribbean Supreme Court, and, on July 8, 2025, the Court of Appeal issued an order staying execution of an injunction from the High Court. In light of the Court of Appeal's… Full filing |
6.3% |
Vivo Capital IX, LLC
13D · may seek influence
filed 2025-03-19
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On February 28, 2025, the Issuer announced a new Board of Directors (the "New Board"). The New Board purportedly does not include Mr. Shan Fu, the Reporting Persons' Board designee since July 2, 2018. Mr. Fu has been excluded from the Issuer's Board of Directors, and requests for his inclusion have gone unanswered. The Reporting Persons intend to take necessary actions to restore Mr. Fu to the Board. The Issuer's announcement also implies that the New Board will take steps to invalidate the July 2, 2018 Private Placement, through which the Reporting Persons acquired the Issuer's common shares and which provided the Issuer with growth capital essential to its subsequent development of the CoronaVac vaccine. The Reporti… Full filing |
6.3% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Vivo Capital, LLC 3.49% of their portfolio | 5.9m $38.2m | Unchanged |
| ORBIMED ADVISORS LLC 3.49% of their portfolio | 2.7m $184.5m | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 1.3m $0 | Unchanged |
| Neumann Advisory Hong Kong Ltd 0.57% of their portfolio | 315.6k $2.0m | Unchanged |
| California Public Employees Retirement System 0.00% of their portfolio | 68.7k $0 | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) 0.00% of their portfolio | 40.0k $0 | Reduced -40.0k |
| Spark Investment Management LLC 0.00% of their portfolio | 29.1k $0 | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 27.7k $0 | Unchanged |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 16.4k $106.3k | Unchanged |
| NAVELLIER & ASSOCIATES INC 0.00% of their portfolio | 13.0k $0 | New |
| MORGAN STANLEY 0.00% of their portfolio | 9.1k $59.2k | Added +2 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 4.6k $29.6k | Reduced -231 |
| UBS Group AG 0.00% of their portfolio | 2.5k $16.0k | Added +250 |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 1.0k $0 | Reduced -1.2k |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.00% of their portfolio | 1.0k $0 | Unchanged |
| Atlantic Edge Private Wealth Management, LLC 0.00% of their portfolio | 1.0k $0 | Unchanged |
| Clearstead Advisors, LLC 0.00% of their portfolio | 500 $0 | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 426 $0 | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 424 $0 | Unchanged |
| Integrated Wealth Concepts LLC 0.00% of their portfolio | 366 $0 | New |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 338 $0 | Unchanged |
| IFP Advisors, Inc 0.00% of their portfolio | 200 $0 | Unchanged |
| HARBOUR INVESTMENTS, INC. 0.00% of their portfolio | 78 $503 | Reduced -5 |
| ASSETMARK, INC 0.00% of their portfolio | 63 $0 | Added +37 |
| Horizon Investments, LLC 0.00% of their portfolio | 52 $336 | Reduced -52 |
| FINANCIAL CONSULATE, INC 0.00% of their portfolio | 23 $0 | Unchanged |
| Financial Gravity Companies, Inc. 0.00% of their portfolio | 11 $0 | First filing |
| Buck Wealth Strategies, LLC 0.00% of their portfolio | 7 $0 | New |
| Transamerica Financial Advisors, LLC 0.00% of their portfolio | 1 $0 | Unchanged |